1-4 of 4
breast cancer stage i
Close
Sort by
Journal Articles

Therapy-Related Myelodysplasia/Acute Myeloid Leukemia (t-MDS/AML) After Conventionally-Treated Breast Cancer: Impact of Cytogenetics on Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT),

Rajinder S. Grover, MD, Vinod Pullarkat, MD, Can-Lan Sun, PhD, Smita Bhatia, MD, MPH, Stephen J. Forman, MD
Journal: Blood
Blood (2011) 118 (21): 4149.
https://doi.org/10.1182/blood.V118.21.4149.4149
Published: 2011
Journal Articles

Breast Cancer Patients Undergoing Adjuvant Chemotherapy Do Not Acquire Activated Protein C Resistance (APC-R).

Madhu N Belur Shivananda, MBBS, MD, Theodore Bell, MS, Edith Sielsch, CRNP, Diane Gaspari, Amir Tabatabai, MD
Journal: Blood
Blood (2009) 114 (22): 5058.
https://doi.org/10.1182/blood.V114.22.5058.5058
Published: 2009
Journal Articles

Do Aromatase Inhibitors Increase Hemoglobin in Women with Breast Cancer?

Daniel J. Lachant, BS, Kanu P. Sharan, MD, Andres Ferber, MD, Robert Somer, MD, Generosa Grana, MD, Neil A. Lachant, MD
Journal: Blood
Blood (2008) 112 (11): 4575.
https://doi.org/10.1182/blood.V112.11.4575.4575
Published: 2008
Journal Articles

Chemotherapy-Induced Activation of Hemostasis: Dalteparin Suppresses Both Thrombin and Interleukin-6 Expression in Breast Cancer Patients Receiving Adjuvant Chemotherapy.

Ilene Ceil Weitz, MD, Howard A. Liebman, MD
Journal: Blood
Blood (2004) 104 (11): 3509.
https://doi.org/10.1182/blood.V104.11.3509.3509
Published: 2004